Abstract:Background Although staphylokianse (SAK) is among the most promising blood dissolving agents, it is far from ideal. It is interesting to hypothesize that the clot lysis efficacy of SAK can be enhanced with direct active platelet binding ability, and at the same time the rethrombosis complication after successful recanalization can be minimized with an antiplatelet aggregation activity. The present study was performed to characterize the functional properties of RGD-SAK, a novel mutant of staphylokinase (SAK). Results By using site-directed mutagenesis, an Arg-Gly-Asp (RGD) motif was engineered in the staphylokinase (SAK). This mutant of SAK designated RGD-SAK was expressed, purified and characterized. Biochemical analysis indicated that RGD-SAK maintained the similar structure and the fibrinolytic function of SAK. Measurement of platelet binding activity in vitro demonstrated that RGD-SAK had a much higher affinity with platelets than SAK. In vitro platelet-rich clot lysis assay demonstrated that the engineered mutant outperformed the non-manipulated SAK. The time required for 50% platelet-rich clot lysis and the concentration required to obtain 50% clot lysis (C 50 ) were reduced significantly across different concentrations of RGD-SAK comparing with SAK. Meanwhile, RGD-SAK was found to inhibit ADP-induced platelet aggregation in a concentration-dependent manner while SAK had negligible effect on platelet aggregation. Conclusion RGD-SAK possessed the bifunction to target platelet-rich clots and to block platelets aggregation, and thus may serve as a more potential thrombolytic agent with platelet-targeted thrombolytic and antiplatelet aggregation activities in compared with SAK.

Construction of novel bifunctional chimeric proteins possessing antitumor and thrombolytic activities.

Construction of Novel Chimeric Proteins Through the Truncation of SEC2 and Sak from Staphylococcus Aureus

Expression and Characterization of Bifunctional Fusion Proteins Possessing Antitumor and Thrombolytic Function for Targeting Therapy.

A Fusion Protein with Improved Thrombolytic Effect and Low Bleeding Risk.

Construction And Characterization Of Trifunctional Single-Chain Urokinase-Type Plasminogen Activators - Trifunctional Plasminogen Activators

NanoSHP099-Targeted SHP2 Inhibition Boosts Ly6C<SUP>low</SUP> Monocytes/Macrophages Differentiation to Accelerate Thrombolysis

Molecular assembly for high-performance bivalent nucleic acid inhibitor

Transcytosis, Antitumor Activity And Toxicity Of Staphylococcal Enterotoxin C2 As An Oral Administration Protein Drug

Characterization of a novel bifunctional mutant of staphylokinase with platelet-targeted thrombolysis and antiplatelet aggregation activities

Two Characteristics of a Recombinant Fusion Protein Composed of Staphylokinase and Hirudin: High Thrombus Affinity and Thrombus-Targeting Release Ofanticoagulant Activity.

Synthesis and Thrombolytic Activity of Pseudopeptides Related to Fibrinogen Fragment

Construction and Expression of Chimeric Antithrombotics with Hirudin and RGD Sequence

Expression and Characterization of Fusion Protein Ttf/sa As a Universal Effector for Targeting Therapy of Blood Coagulation

Construction and Characterization of Novel Staphylokinase Variants with Antiplatelet Aggregation Activity and Reduced Immunogenecity.

Synthesis, characterization, and targeted chemotherapy of SCT200-linker-monomethyl auristatin E conjugates

Thrombolytic and anticoagulant effects of a recombinant staphylokinase-hirudin fusion protein

Novel Recombinant Thrombolytic and Antithrombotic Staphylokinase Variants with an RGD Motif at Their N‐termini

Simultaneous Elimination of T- and B-Cell Epitope by Structure-Based Mutagenesis of Single Glu80 Residue Within Recombinant Staphylokinase

CHIMERIC FIBRINOLYTIC ENZYMES: PROGRESS AND PROSPECTIVE

Molecular Modeling and Affinity Determination of Scfv Antibody: Proper Linker Peptide Enhances Its Activity

Chiral Protein Supraparticles for Tumor Suppression and Synergistic Immunotherapy: an Enabling Strategy for Bioactive Supramolecular Chirality Construction